Pillsbury Advises TJM Labs on $75 Million Series B Financing
July 09, 2026
July 09, 2026
NEW YORK, July 9 -- Pillsbury, a law firm, issued the following news release:
* * *
Pillsbury Advises TJM Labs on $75 Million Series B Financing
Pillsbury advised TJM Labs, the leading pharmacy AI platform automating operational work for pharmacies, on its $75 million Series B funding round. The transaction follows the company's $10 million Series A and $15 million Series A-1 financings, bringing TJM Labs' total capital raised to $100 million acro . . .
* * *
Pillsbury Advises TJM Labs on $75 Million Series B Financing
Pillsbury advised TJM Labs, the leading pharmacy AI platform automating operational work for pharmacies, on its $75 million Series B funding round. The transaction follows the company's $10 million Series A and $15 million Series A-1 financings, bringing TJM Labs' total capital raised to $100 million acro . . .